-transparent.png){kind=logo}
Twenty-five patients with metastatic prostate cancer resistant to primary hormone therapy, received high-dose intravenous diethylstilbestrol diphosphate (Stilphostrol [Miles Pharm], DES-P) in a Phase II study using established response criteria. Objective response rate was 17%, while 22% of the patients were subjectively improved. Moderate gastrointestinal toxicity was reported in 10 patients (40%). Thromboembolic complications were seen in 2 (8%). The role of high-dose Stilphostrol in the treatment of hormone-resistant prostate cancer is limited.
Related Publications
D L Citrin, and
M S Kies, and
C B Wallemark, and
J Khandekar, and
E Kaplan, and
F Camacho, and
R Lind
August 1998,
Nihon rinsho. Japanese journal of clinical medicine,
D L Citrin, and
M S Kies, and
C B Wallemark, and
J Khandekar, and
E Kaplan, and
F Camacho, and
R Lind
October 1973,
Canadian Medical Association journal,
D L Citrin, and
M S Kies, and
C B Wallemark, and
J Khandekar, and
E Kaplan, and
F Camacho, and
R Lind
September 2001,
Scandinavian journal of urology and nephrology,
D L Citrin, and
M S Kies, and
C B Wallemark, and
J Khandekar, and
E Kaplan, and
F Camacho, and
R Lind
July 1956,
Deutsche medizinische Wochenschrift (1946),
D L Citrin, and
M S Kies, and
C B Wallemark, and
J Khandekar, and
E Kaplan, and
F Camacho, and
R Lind
December 2002,
Nihon rinsho. Japanese journal of clinical medicine,
D L Citrin, and
M S Kies, and
C B Wallemark, and
J Khandekar, and
E Kaplan, and
F Camacho, and
R Lind
September 1993,
Hinyokika kiyo. Acta urologica Japonica,
D L Citrin, and
M S Kies, and
C B Wallemark, and
J Khandekar, and
E Kaplan, and
F Camacho, and
R Lind
April 1994,
Revue du rhumatisme (Ed. francaise : 1993),
D L Citrin, and
M S Kies, and
C B Wallemark, and
J Khandekar, and
E Kaplan, and
F Camacho, and
R Lind
September 1999,
Clinical cancer research : an official journal of the American Association for Cancer Research,
D L Citrin, and
M S Kies, and
C B Wallemark, and
J Khandekar, and
E Kaplan, and
F Camacho, and
R Lind
October 1999,
Endocrine journal,
D L Citrin, and
M S Kies, and
C B Wallemark, and
J Khandekar, and
E Kaplan, and
F Camacho, and
R Lind
June 2007,
The Journal of urology,
